FBN1 and Marfan syndrome: Though genetic testing is not mandatory to establish the diagnosis of MFS, with the growing knowledge of genotype-phenotype correlation, FBN1 sequencing plays an increasingly important role in the clinical management of MFS and related fibrillinopathies in terms of risk stratification, disease monitoring, and personalized medication.